Related Experiment Video
Updated: Mar 29, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
MicroRNAs: Modulators of the Ras Oncogenes in Oral Cancer
Avaniyapuram Kannan Murugan1, Arasambattu Kannan Munirajan2, Ali S Alzahrani1
1Department of Molecular Oncology, King Faisal Specialist Hospital and Research Center, Riyadh, Kingdom of Saudi Arabia.
Abstract:
Oral squamous cell carcinoma (OSCC) of the head and neck is one of the six most common cancers in the world. OSCC remains the most common cause of cancer deaths in Asian countries. Conventional treatments for OSCC have not improved the overall 5 years survival and therefore alternative therapeutic targets are often sought. Ras is one of the most frequently deregulated oncogenes in oral cancer. Direct targeting the ras has proven unrealistic and hence, exploring and understanding alternative pathways and/or molecules which regulate ras and its signaling that could pave the way for novel molecular targets and therapy for oral cancer. Recently, microRNAs (miRNAs) have been reported to regulate ras oncogenes in human cancers. In this article, we address the microRNA-mediated regulation of the ras oncogenes in oral cancer. We describe extensively the tumor suppressive and oncogenic roles of miRNAs in regulation of ras oncogenes in OSCC. We also discuss the role of miRNA-mediated ras regulation in therapeutic determination of oral cancer. Complete understanding of the miRNA regulation of ras oncogenes in oral cancer may facilitate to plan better strategies for diagnosis, molecular therapeutic targeting and the overall prognosis of this common and deadly cancer.
Insights
MicroRNAs (miRNAs) regulate ras oncogenes in oral squamous cell carcinoma (OSCC). Understanding these miRNA roles offers new therapeutic targets for this deadly cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Oral squamous cell carcinoma (OSCC) is a prevalent cancer globally and a leading cause of cancer mortality in Asia.
- Current OSCC treatments show limited improvement in 5-year survival rates, necessitating alternative therapeutic strategies.
- Ras oncogenes are frequently dysregulated in oral cancer, but direct targeting remains challenging.
Purpose of the Study:
- To explore microRNA (miRNA)-mediated regulation of ras oncogenes in oral cancer.
- To elucidate the tumor-suppressive and oncogenic functions of miRNAs in OSCC ras pathway regulation.
- To discuss the implications of miRNA-ras interactions for novel therapeutic approaches in oral cancer.
Main Methods:
- Literature review and analysis of existing research on miRNA and ras oncogene interactions in OSCC.
- Examination of the dual roles (tumor suppressive and oncogenic) of specific miRNAs.
- Discussion of the potential of miRNA-based therapies targeting the ras pathway.
Main Results:
- MicroRNAs play a significant role in modulating the activity of ras oncogenes in oral cancer.
- Specific miRNAs can act as tumor suppressors or oncogenes by regulating ras signaling.
- Dysregulation of miRNA-ras interactions contributes to OSCC development and progression.
Conclusions:
- Understanding miRNA-mediated regulation of ras oncogenes is crucial for developing targeted therapies for OSCC.
- Targeting miRNA-ras pathways presents a promising avenue for improving diagnosis and treatment outcomes.
- Further research into these molecular mechanisms can enhance strategies for managing oral cancer prognosis.
Related Concept Videos
The Ras Gene
Ras is a...
Abnormal Proliferation
MicroRNAs
MicroRNAs
MicroRNAs
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:

